Advertisement

Citations to this article

Abstract

Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas. pSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR. Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis. Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels. In addition, reduction of IL-6 levels by RNA interference led to a decrease in tumorigenesis. Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade. Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased production and release of IL-6. Finally, immunohistochemical analysis revealed a positive correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas. Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by means of IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.

Authors

Sizhi Paul Gao ... Bayard Clarkson, Jacqueline F. Bromberg

×

Total citations by year in Crossref

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 32 25 24 19 19 26 11 1 158
Citation information

Citations to this article in Crossref (158)

Title and authors Publication Year
Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis
JW Franses, NC Drosu, WJ Gibson, VC Chitalia, ER Edelman
International journal of cancer. Journal international du cancer 2013
Targeting the tumor microenvironment
E Bournazou, J Bromberg
JAK-STAT 2013
STAT3 expression correlates with prognosis of thymic epithelial tumors
C Li, Z Wang, Y Liu, P Wang, R Zhang
Journal of Cardiothoracic Surgery 2013
Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)
C Garbers, F Kuck, S Aparicio-Siegmund, K Konzak, M Kessenbrock, A Sommerfeld, D Häussinger, PA Lang, D Brenner, TW Mak, S Rose-John, F Essmann, K Schulze-Osthoff, RP Piekorz, J Scheller
Cell cycle (Georgetown, Tex.) 2013
Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
TL Putoczki, S Thiem, A Loving, RA Busuttil, NJ Wilson, PK Ziegler, PM Nguyen, A Preaudet, R Farid, KM Edwards, Y Boglev, RB Luwor, A Jarnicki, D Horst, A Boussioutas, JK Heath, OM Sieber, I Pleines, BT Kile, A Nash, FR Greten, BS McKenzie, M Ernst
Cancer Cell 2013
Smoking-Induced CXCL14 Expression in the Human Airway Epithelium Links Chronic Obstructive Pulmonary Disease to Lung Cancer
R Shaykhiev, R Sackrowitz, T Fukui, WL Zuo, IW Chao, Y Strulovici-Barel, RJ Downey, RG Crystal
American journal of respiratory cell and molecular biology 2013
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Y Fan, R Mao, J Yang
Protein & Cell 2013
Inducers of immunogenic cancer cell death
AM Dudek, AD Garg, DV Krysko, DD Ruysscher, P Agostinis
Cytokine & Growth Factor Reviews 2013
EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells
R Ghildiyal, D Dixit, E Sen
Molecular Carcinogenesis 2012
DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
UJ Yun, SE Park, YS Jo, J Kim, DY Shin
Cancer Letters 2012
Acetylation modulates the STAT signaling code
M Wieczorek, T Ginter, P Brand, T Heinzel, OH Krämer
Cytokine & Growth Factor Reviews 2012
Stat3: Linking inflammation to (gastrointestinal) tumourigenesis
M Ernst, TL Putoczki
Clinical and Experimental Pharmacology and Physiology 2012
Interleukin-6 signaling pathway in targeted therapy for cancer
Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang
Cancer Treatment Reviews 2012
A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk
J Chen, RY Liu, L Yang, J Zhao, X Zhao, D Lu, N Yi, B Han, XF Chen, K Zhang, J He, Z Lei, Y Zhou, B Pasche, X Li, HT Zhang
Journal of Cancer Research and Clinical Oncology 2012
ER stress-induced inflammation: does it aid or impede disease progression?
AD Garg, A Kaczmarek, O Krysko, P Vandenabeele, DV Krysko, P Agostinis
Trends in Molecular Medicine 2012
Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α
K Kanda, H Komekado, T Sawabu, S Ishizu, Y Nakanishi, M Nakatsuji, R Akitake-Kawano, M Ohno, Y Hiraoka, M Kawada, K Kawada, Y Sakai, K Matsumoto, M Kunichika, T Kimura, H Seno, E Nishi, T Chiba
EMBO Molecular Medicine 2012
Radioimmunoimaging with Mixed Monoclonal Antibodies of Nude Mice Bearing Human Lung Adenocarcinoma Xenografts
D Duan, SL Li, YQ Zhu, T Zhang, CM Lei, XH Cheng
Asian Pacific Journal of Cancer Prevention 2012
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
H Yi, HJ Cho, SM Cho, K Jo, JA Park, SH Lee, BJ Chang, JS Kim, HC Shin
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2012
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation
D Harada, N Takigawa, N Ochi, T Ninomiya, M Yasugi, T Kubo, H Takeda, E Ichihara, K Ohashi, S Takata, M Tanimoto, K Kiura
Cancer Science 2012
STAT3 negatively regulates thyroid tumorigenesis
JP Couto, L Daly, A Almeida, JA Knauf, JA Fagin, M Sobrinho-Simões, J Lima, V Máximo, P Soares, D Lyden, JF Bromberg
Proceedings of the National Academy of Sciences 2012
Determinants of the extent and duration of STAT3 signaling
B Groner
JAK-STAT 2012
p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway
P Ozenne, D Dayde, E Brambilla, B Eymin, S Gazzeri
Oncogene 2012
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
X Jin, SH Kim, HM Jeon, S Beck, YW Sohn, J Yin, JK Kim, YC Lim, JH Lee, SH Kim, SH Kang, X Pian, MS Song, JB Park, YS Chae, YG Chung, SH Lee, YJ Choi, DH Nam, YK Choi, H Kim
Brain 2012
Impact of Collection and Storage of Lung Tumor Tissue on Whole Genome Expression Profiling
MB Freidin, N Bhudia, E Lim, AG Nicholson, WO Cookson, MF Moffatt
Journal of Molecular Diagnostics 2012
Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
HS Hsu, JH Lin, TW Hsu, K Su, CW Wang, KY Yang, SH Chiou, SC Hung
Lung Cancer 2012

Advertisement
Advertisement